Please login to the form below

Not currently logged in
Email:
Password:

BlueRock Therapeutics

This page shows the latest BlueRock Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy

Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy

In 2019, Bayer bought out its private equity partner Versant Ventures and founders in BlueRock Therapeutics for $240m. ... In 2019, Bayer bought out its private equity partner Versant Ventures and founders in BlueRock Therapeutics for $240m, three years

Latest news

  • Bayer strengthens cell and gene therapy focus with new platform Bayer strengthens cell and gene therapy focus with new platform

    The new cell and gene therapy platform will house both AskBio and another of Bayer’s recently acquired firms, BlueRock Therapeutics, under one roof. ... The German pharma company also bought out its private equity partner Versant Venture and founders

  • Bayer pays an initial $2bn for gene therapy firm AskBio Bayer pays an initial $2bn for gene therapy firm AskBio

    Samulski also created two AskBio subsidiaries, Bamboo Therapeutics and Chatham Therapeutics, which focused on Duchenne muscular dystrophy and haemophilia respectively. ... Bayer said that the AskBio acquisition complements its previous buy-out deal for

  • Bayer takes control of BlueRock stem cell joint venture Bayer takes control of BlueRock stem cell joint venture

    Deal values BlueRock at $1bn. Bayer is buying out private equity partner Versant Ventures and founders in its cell therapy joint venture BlueRock Therapeutics for $240m, three years after setting up ... The venture unit followed that a few weeks later

  • Bayer helps bankroll new stem cell company BlueRock Bayer helps bankroll new stem cell company BlueRock

    BlueRock Therapeutics comes into being with one of the largest debut financings ever granted to a biotech company, and is the second start-up to be backed by Bayer's investment ... BlueRock will have research and development operations in Toronto, New

More from news
Approximately 3 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Visformatics (VISFO)

A team of strategic decision specialists with over 30+ years in the pharma space, we give you confidence through experience....

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...